3D structure of DNA forms defined room for dissociated lncRNAs to activate gene expression

Enhancers are regulatory regions of the DNA, giving rise to “long non-coding RNAs” (lncRNAs), which are known as crucial regulators of gene expression. Scientists from the Max Planck Institute for Molecular Genetics in Berlin now have shown that a...

More

ProBioGen signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project

ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins, today announced that it has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held...

More

Grants4Apps Global Dealmaker 2018

Take this unique opportunity to acquire Bayer as a customer

More

Switching off insatiable hunger

A new drug to help young patients with genetic obesity

More

Revolutionary milk analysis platform allows for multiplex analysis of 100 antibiotic residues and toxins in a single test

Unisensor produces the lateral flow biosticks for its unique Extenso platform with SCIENION’s unrivalled sciFLEXARRAYER ultra-low volume dispensers

More

NOXXON PHARMA N.V. REPORTS 2017 FINANCIAL RESULTS

Year marked by advance of clinical strategy

More

TU Berlin start-up Cellbricks wins World Summit Award

More

MOLOGEN reached key strategic milestones and successfully implements capital measures in 2017

First licensing agreement for lead compound lefitolimod concluded | Significant progress in studies | Company funding secured until the end of 2018 through successful capital measures

More

SPARK project receives millions in funding for a new epilepsy therapy

Charité clinician Regine Heilbronn and her research team convince the Federal Ministry of Education and Research (BMBF) at the GO-Bio Competition, daring to take the leap from the laboratory to medical application. The scientists were chosen for...

More

ProBioGen signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project

Berlin, Germany, April 18th, 2018

More
Show more items